PC
VRNA

Polar Capital’s Verona Pharma VRNA Stock Holding History

Polar Capital’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$6.24M Buy
+1,000,000
New +$6.91M 0.05% 201
2019
Q4 		– Sell
-100,000
Closed -$457K – 310
2019
Q3 		$457K Hold
100,000
– – ﹤0.01% 269
2019
Q2 		$510K Hold
100,000
– – ﹤0.01% 271
2019
Q1 		$650K Hold
100,000
– – 0.01% 253
2018
Q4 		$965K Hold
100,000
– – 0.01% 241
2018
Q3 		$1.25M Hold
100,000
– – 0.01% 255
2018
Q2 		$1.37M Hold
100,000
– – 0.01% 245
2018
Q1 		$2M Buy
100,000
+4,851
+5% +$70.1K 0.02% 243
2017
Q4 		$1.13M Buy
95,149
+19,232
+25% +$250K 0.01% 242
2017
Q3 		$1.17M Buy
+75,917
New +$1M 0.01% 234

Other funds holding VRNA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Polar Capital's VRNA Position: Q3 2020 in Review

Polar Capital opened a new position in Verona Pharma (VRNA) in Q3 2020: 1,000,000 shares worth $6.24M. The stake represents 0.05% of the portfolio and ranks #201 among its holdings. This is a return to the name: Polar Capital previously reported a position in VRNA as recently as Q3 2019.

Polar Capital first reported a position in VRNA in Q3 2017 and has held it in 10 quarters since. 28 funds tracked by Wall St. Rank hold VRNA as of Q3 2020.

  • Polar Capital held 1,000,000 shares of Verona Pharma worth $6.24M as of Q3 2020.
  • Verona Pharma was a new Polar Capital position in Q3 2020.
  • Verona Pharma made up 0.05% of Polar Capital's portfolio in Q3 2020, its #201 holding.
  • Polar Capital first reported a position in Verona Pharma in Q3 2017 and has held it in 10 quarters since.
  • 28 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.